PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

CPAP rapidly improves blood pressure and arterial tone in adults with sleep apnea

Compliance with CPAP therapy may help prevent cardiovascular complications

2014-06-02
(Press-News.org) DARIEN, IL – A new study suggests that continuous positive airway pressure (CPAP) therapy rapidly improves blood pressure and arterial tone in adults with obstructive sleep apnea (OSA).

Results show that there was a significant reduction in systolic and diastolic blood pressures among sleep apnea patients who were compliant with CPAP therapy for three months. Successful treatment of sleep apnea also was associated with decreased vascular tone and arterial stiffness. Following one week of treatment withdrawal, these improvements disappeared and reverted to baseline values.

"We were surprised by the very rapid improvements in arterial tone, seen as early as four weeks into treatment, and how quickly they reversed after only a few days of treatment withdrawal," said principal investigator Claudia Korcarz, DVM, RDCS, manager and senior scientist at the University of Wisconsin Atherosclerosis Imaging Research Program (UW AIRP) in Madison. "We noticed these improvements in young, normotensive subjects. These findings demonstrate that the vascular effects of sleep apnea are reversible if treated early in the disease process, suggesting that we might be able to mitigate the long-term risk of chronic exposure to OSA."

The research abstract was published recently in an online supplement of the journal Sleep and will be presented Wednesday, June 4, in Minneapolis, Minnesota, at SLEEP 2014, the 28th annual meeting of the Associated Professional Sleep Societies LLC.

The study group comprised 47 adults with a mean age of about 41 years who had been recently diagnosed with OSA. They were evaluated before and after three months of CPAP therapy, as well as one week after treatment withdrawal. Carotid to radial artery pulse wave velocity and central aortic blood pressures were obtained by applanation tonometry. Brachial artery size and flow-mediated dilation were measured with B-mode ultrasound.

Subjects were considered to be compliant with treatment if they used CPAP therapy for at least four hours per night. Thirty-seven of the 47 participants met this criteria, using CPAP therapy for an average of 6.1 hours per night.

Korcarz noted that these findings reinforce that the effective treatment of OSA can have positive implications for cardiovascular health.

"The early diagnosis and treatment with well-monitored, continuous use of CPAP therapy in otherwise healthy young adults with moderate to severe obstructive sleep apnea might prevent the future development of hypertension and reduce the risk of cardiovascular complications associated with the disease," said Korcarz.

The AASM reports that obstructive sleep apnea is a common sleep illness affecting up to seven percent of men and five percent of women. It involves repetitive episodes of complete or partial upper airway obstruction occurring during sleep despite an ongoing effort to breathe. The most effective treatment option for OSA is CPAP therapy, which helps keep the airway open by providing a stream of air through a mask that is worn during sleep.

INFORMATION: The research was performed under the supervision of Dr. Ruth Benca and Dr. James Stein in the University of Wisconsin School of Medicine and Public Health.

For a copy of the abstract, "Continuous Positive Airway Pressure Rapidly Improves Blood Pressure and Arterial Constriction in Young Adults," or to arrange an interview with Claudia Korcarz or an AASM spokesperson, please contact AASM Communications Coordinator Lynn Celmer at 630-737-9700, ext. 9364, or lcelmer@aasmnet.org.

Established in 1975, the American Academy of Sleep Medicine (AASM) improves sleep health and promotes high quality patient centered care through advocacy, education, strategic research, and practice standards. With about 9,000 members, the AASM is the largest professional membership society for physicians, scientists and other health care providers dedicated to sleep medicine. For more information, visit http://www.aasmnet.org.


ELSE PRESS RELEASES FROM THIS DATE:

Studies reveal new strategies to improve quality of life

2014-06-02
CHICAGO – Key studies released today at the 50th Annual Meeting of the American Society of Clinical Oncology (ASCO) identify new strategies for easing the short- and long-term effects of cancer therapy and improving the quality of life of patients with cancer, as well as their caregivers. "We've made incredible strides in cancer treatment, and more cancer survivors are alive today than ever before. But oncology isn't just about helping people live longer – we need to ensure that patients have the best quality of life possible at every stage of their cancer journey, from ...

Studies reveal potential new targeted therapies for common, hard-to-treat cancers

2014-06-02
CHICAGO – Positive results from four clinical trials of investigational targeted drugs for advanced ovarian, lung, and thyroid cancers, and chronic lymphocytic leukemia were highlighted today at the 50th Annual Meeting of the American Society of Clinical Oncology (ASCO). Findings from the mid- and late-stage trials suggest new ways to slow disease progression and improve survival for patients who experience relapses or resistance to available treatments. "Cancer relapses and treatment resistance have always been among the most daunting challenges in cancer care," said ...

Clinical trial shows drug combination may be highly effective in recurrent ovarian cancer

Clinical trial shows drug combination may be highly effective in recurrent ovarian cancer
2014-06-02
VIDEO: Dr. Joyce Liu talks about her ovarian cancer research at ASCO 2014. Click here for more information. CHICAGO –– Significant improvement with the use of a combination drug therapy for recurrent ovarian cancer was reported at the annual meeting of the American Society of Clinical Oncology (ASCO) meeting in Chicago today. This is the first ovarian cancer study to use a combination of drugs that could be taken orally. The drugs were tested in a phase I combination study followed ...

Drug combination extends survival by more than a year in metastatic prostate cancer

Drug combination extends survival by more than a year in metastatic prostate cancer
2014-06-02
VIDEO: Dr. Christopher Sweeney talks about his new study showing a drug combination extends survival by more than a year in metastatic prostate cancer. Click here for more information. CHICAGO – Men with newly diagnosed metastatic, hormone-sensitive prostate cancer lived more than a year longer when they received a chemotherapy drug as initial treatment instead of waiting to for the disease to become resistant to hormone-blockers, report scientists from Dana-Farber Cancer Institute ...

Prostate cancer drug delivers benefits before chemotherapy

Prostate cancer drug delivers benefits before chemotherapy
2014-06-02
PORTLAND, Ore. – A drug used to treat men with late-stage prostate cancer proved effective in stemming progression of the disease in research participants who had not yet received chemotherapy and extended their survival, according to results from a multi-national Phase III clinical trial led by the Knight Cancer Institute at Oregon Health & Science University (OHSU). A comprehensive analysis of the study's results ― published in June 1 online edition of the New England Journal of Medicine and to be presented at the American Society of Clinical Oncology (ASCO) annual ...

Researchers to provide update on Phase II trial of vaccine for malignant brain tumors

2014-06-02
LOS ANGELES (STRICTLY EMBARGOED UNTIL 7:30 A.M. EDT on JUNE 1, 2014 - ASCO Abstract No. 2005) – A multicenter team of investigators, led by researchers from the Cedars-Sinai Department of Neurosurgery, the Cedars-Sinai Maxine Dunitz Neurosurgical Institute and Dana-Farber Cancer Institute in Boston, have found in a Phase II clinical trial that an immune system-boosting therapy slowed the recurrence of glioblastoma multiforme, or GBM, the most common and deadly malignant brain tumor. They will present their findings in an oral presentation June 1 at the annual meeting ...

Major advances in breast, prostate, colorectal cancer featured at ASCO Annual Meeting

2014-06-02
CHICAGO – Findings from four phase III clinical trials in breast, prostate, and colorectal cancers were released today at the 50th Annual Meeting of the American Society of Clinical Oncology (ASCO). The studies were presented in ASCO's Plenary session, which features the meeting's most important clinical cancer research with the greatest potential to impact patient care. These pivotal studies reveal new ways to optimize commonly used chemotherapy, hormone therapies, and newer targeted drugs, and answer critical questions about the comparative effectiveness of two common ...

World's best thermometer made from light

Worlds best thermometer made from light
2014-06-02
University of Adelaide physics researchers have produced the world's most sensitive thermometer – three times more precise than the best thermometers in existence. Published in the journal Physical Review Letters, the researchers from the University's Institute for Photonics and Advanced Sensing (IPAS) report they have been able to measure temperature with a precision of 30 billionths of a degree. "We believe this is the best measurement ever made of temperature − at room temperature," says project leader Professor Andre Luiten, Chair of Experimental Physics in ...

Breakthrough in energy storage: Electrical cables that can store energy

Breakthrough in energy storage: Electrical cables that can store energy
2014-06-02
VIDEO: Dr. Thomas and his team light an LED using energy stored in the outside coatings of an electrical cable. Click here for more information. Imagine being able to carry all the juice you needed to power your MP3 player, smartphone and electric car in the fabric of your jacket? Sounds like science fiction, but it may become a reality thanks to breakthrough technology developed at a University of Central Florida research lab. So far electrical cables are used only to transmit ...

Common cholesterol drug greatly alters inflammatory response to common cold

2014-06-02
Cold season may be just behind us, but a new discovery may shed light on how this common condition triggers asthma attacks. In a new research report published in the June 2014 issue of the Journal of Leukocyte Biology, researchers show that in individuals with asthma, statins significantly reduce the in vitro inflammatory response of human monocytes to rhinovirus (RV), the cause of the common cold. Not only does this discovery suggest that statins could help prevent or reduce the severity of asthma symptoms resulting from colds, but may also open the doors to further research ...

LAST 30 PRESS RELEASES:

Interpreting population mean treatment effects in the Kansas City Cardiomyopathy Questionnaire

Targeting carbohydrate metabolism in colorectal cancer: Synergy of therapies

Stress makes mice’s memories less specific

Research finds no significant negative impact of repealing a Depression-era law allowing companies to pay workers with disabilities below minimum wage

Resilience index needed to keep us within planet’s ‘safe operating space’

How stress is fundamentally changing our memories

Time in nature benefits children with mental health difficulties: study

In vitro model enables study of age-specific responses to COVID mRNA vaccines

Sitting too long can harm heart health, even for active people

International cancer organizations present collaborative work during oncology event in China

One or many? Exploring the population groups of the largest animal on Earth

ETRI-F&U Credit Information Co., Ltd., opens a new path for AI-based professional consultation

New evidence links gut microbiome to chronic disease outcomes

Family Heart Foundation appoints Dr. Seth Baum as Chairman of the Board of Directors

New route to ‘quantum spin liquid’ materials discovered for first time

Chang’e-6 basalts offer insights on lunar farside volcanism

Chang’e-6 lunar samples reveal 2.83-billion-year-old basalt with depleted mantle source

Zinc deficiency promotes Acinetobacter lung infection: study

How optogenetics can put the brakes on epilepsy seizures

Children exposed to antiseizure meds during pregnancy face neurodevelopmental risks, Drexel study finds

Adding immunotherapy to neoadjuvant chemoradiation may improve outcomes in esophageal cancer

Scientists transform blood into regenerative materials, paving the way for personalized, blood-based, 3D-printed implants

Maarja Öpik to take up the position of New Phytologist Editor-in-Chief from January 2025

Mountain lions coexist with outdoor recreationists by taking the night shift

Students who use dating apps take more risks with their sexual health

Breakthrough idea for CCU technology commercialization from 'carbon cycle of the earth'

Keck Hospital of USC earns an ‘A’ Hospital Safety Grade from The Leapfrog Group

Depression research pioneer Dr. Philip Gold maps disease's full-body impact

Rapid growth of global wildland-urban interface associated with wildfire risk, study shows

Generation of rat offspring from ovarian oocytes by Cross-species transplantation

[Press-News.org] CPAP rapidly improves blood pressure and arterial tone in adults with sleep apnea
Compliance with CPAP therapy may help prevent cardiovascular complications